Literature DB >> 20649826

Short ileal segment for orthotopic neobladder: a feasibility study.

Predrag Aleksic1, Vladimir Bancevic, Novak Milovic, Branko Kosevic, Dusica M Stamenkovic, Menelaos Karanikolas, Zoran M Campara, Mirko Jovanovic.   

Abstract

OBJECTIVES: The objective of this study was to present the construction of a neobladder with a modified pouch technique using 25-35 cm of terminal ileum.
METHODS: Thirty-eight patients whose pouch was constructed from 25-35 cm of terminal ileum (short pouch [SP] group) were prospectively evaluated vs 41 patients whose pouch was constructed from 50-70 cm of terminal ileum (long pouch group). Pouch volume, post-void residual (PVR) volume, need for catheterization, continence and voiding frequency were evaluated at 3 and 12 months after surgery.
RESULTS: SP group patients had significantly smaller pouch capacity (440 vs 840 mL, P < 0.001) at month 12, and smaller PVR at postoperative months 3 (11 [0-43]vs 40 [0-147] mL, P < 0.001) and 12 (10 [0-90]vs 72 [0-570] mL, P < 0.001). SP group patients had significantly higher voiding frequency on postoperative month 3 (10 vs 9, P < 0.001) and 12 (7 vs 6, P < 0.005). Continence was significantly improved in the SP group compared with the long pouch group after 12 months (63.2% vs 34.1%, respectively, P = 0.034). Full continence improved significantly over time (P < 0.001) in the SP group, from 26.3% at month 3 to 63.2% at month 12.
CONCLUSION: A pouch constructed from 25-35 cm of terminal ileum provides adequate capacity, smaller PVR, satisfactory continence and a better 24-h voiding frequency pattern during the first postoperative year.

Entities:  

Mesh:

Year:  2010        PMID: 20649826     DOI: 10.1111/j.1442-2042.2010.02599.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  3 in total

Review 1.  Orthotopic neobladder reconstruction.

Authors:  Dwayne T S Chang; Nathan Lawrentschuk
Journal:  Urol Ann       Date:  2015 Jan-Mar

2.  Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].

Authors:  Shingo Hatakeyama; Takuya Koie; Takuma Narita; Shogo Hosogoe; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 3.  Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives.

Authors:  Liang G Qu; Nathan Lawrentschuk
Journal:  Res Rep Urol       Date:  2019-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.